Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 7.96
-0.05 (-0.62%)
Aug 4, 2026, 3:04 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.05 billion as of August 4, 2026. Its market cap has decreased by -23.70% in one year.
Market Cap
3.05B
Enterprise Value
2.99B
Revenue
2.81B
Ranking
n/a
PE Ratio
19.41
Stock Price
7.96
ChartMarket Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.05B, an increase of 68.73%. That is a compound annual growth rate of 3.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 3.05B | -10.40% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Obio Technology (Group) Corp. | 3.48B |
| Shanghai Shen Lian Biomedical | 3.42B |
| Lifecome Biochemistry | 3.34B |
| Jiangsu Bioperfectus Technologies | 3.25B |
| Hinova Pharmaceuticals | 3.24B |
| Shanghai Serum Bio-Technology | 3.12B |
| Zhejiang Shouxiangu Pharmaceutical | 2.94B |
| Guanhao Biotech | 2.87B |